Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy

Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E832-40. doi: 10.1152/ajpendo.00002.2012. Epub 2012 Jul 17.

Abstract

Changes in adipose tissue metabolism are central to adaptation of whole body energy homeostasis to pregnancy. To gain insight into the molecular mechanisms supporting tissue remodeling, we have characterized the longitudinal changes of the adipose transcriptome in human pregnancy. Healthy nonobese women recruited pregravid were followed in early (8-12 wk) and in late (36-38 wk) pregnancy. Adipose tissue biopsies were obtained in the fasting state from the gluteal depot. The adipose transcriptome was examined via whole genome DNA microarray. Expression of immune-related genes and extracellular matrix components was measured using real-time RT-PCR. Adipose mass, adipocyte size, and cell number increased in late pregnancy compared with pregravid measurements (P < 0.001) but remained unchanged in early pregnancy. The adipose transcriptome evolved during pregnancy with 10-15% of genes being differently expressed compared with pregravid. Functional gene cluster analysis revealed that the early molecular changes affected immune responses, angiogenesis, matrix remodeling, and lipid biosynthesis. Increased expression of macrophage markers (CD68, CD14, and the mannose-6 phosphate receptor) emphasized the recruitment of the immune network in both early and late pregnancy. The TLR4/NF-κB signaling pathway was enhanced specifically in relation to inflammatory adipokines and chemokines genes. We conclude that early recruitment of metabolic and immune molecular networks precedes the appearance of pregnancy-related physiological changes in adipose tissue. This biphasic pattern suggests that physiological inflammation is an early step preceding the development of insulin resistance, which peaks in late pregnancy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adaptation, Physiological*
  • Adipokines / genetics
  • Adipokines / immunology
  • Adipokines / metabolism
  • Adipose Tissue / immunology
  • Adipose Tissue / physiology*
  • Antigens, CD / biosynthesis
  • Antigens, CD / immunology
  • Antigens, Differentiation, Myelomonocytic / biosynthesis
  • Antigens, Differentiation, Myelomonocytic / immunology
  • Chemokines / genetics
  • Chemokines / immunology
  • Chemokines / metabolism
  • Female
  • Humans
  • Inflammation / genetics
  • Inflammation / immunology
  • Inflammation / physiopathology*
  • Lipid Metabolism / genetics
  • Lipid Metabolism / immunology
  • Lipid Metabolism / physiology
  • Lipopolysaccharide Receptors / biosynthesis
  • Lipopolysaccharide Receptors / immunology
  • NF-kappa B / immunology
  • NF-kappa B / metabolism
  • Neovascularization, Physiologic / genetics
  • Neovascularization, Physiologic / immunology
  • Pregnancy
  • Pregnancy Trimester, First / genetics
  • Pregnancy Trimester, First / immunology
  • Pregnancy Trimester, First / physiology*
  • Pregnancy Trimester, Third / genetics
  • Pregnancy Trimester, Third / immunology
  • Pregnancy Trimester, Third / physiology*
  • Receptor, IGF Type 2 / biosynthesis
  • Receptor, IGF Type 2 / immunology
  • Signal Transduction / genetics
  • Signal Transduction / immunology
  • Signal Transduction / physiology
  • Toll-Like Receptor 4 / immunology
  • Toll-Like Receptor 4 / metabolism
  • Transcriptome / genetics
  • Transcriptome / immunology
  • Transcriptome / physiology

Substances

  • Adipokines
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 antigen, human
  • Chemokines
  • Lipopolysaccharide Receptors
  • NF-kappa B
  • Receptor, IGF Type 2
  • TLR4 protein, human
  • Toll-Like Receptor 4